Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Using ordinal outcomes to construct and select biomarker combinations for single-level prediction.

Meisner A, Parikh CR, Kerr KF.

Diagn Progn Res. 2018 May 21;2:8. doi: 10.1186/s41512-018-0028-3. eCollection 2018.

2.

Reply.

Kerr KF, Thiessen-Philbrook HR, Parikh CR.

Ann Thorac Surg. 2018 Aug;106(2):641. doi: 10.1016/j.athoracsur.2018.02.084. Epub 2018 Apr 5. No abstract available.

PMID:
29626457
3.

Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study.

Meisner A, Kerr KF, Thiessen-Philbrook H, Wilson FP, Garg AX, Shlipak MG, Kavsak P, Whitlock RP, Coca SG, Parikh CR.

Biomark Res. 2018 Jan 12;6:3. doi: 10.1186/s40364-018-0117-z. eCollection 2018.

4.

Biomarker combinations for diagnosis and prognosis in multicenter studies: Principles and methods.

Meisner A, Parikh CR, Kerr KF.

Stat Methods Med Res. 2019 Apr;28(4):969-985. doi: 10.1177/0962280217740392. Epub 2017 Nov 20.

PMID:
29157119
5.

Interleukin-8 and Tumor Necrosis Factor Predict Acute Kidney Injury After Pediatric Cardiac Surgery.

de Fontnouvelle CA, Greenberg JH, Thiessen-Philbrook HR, Zappitelli M, Roth J, Kerr KF, Devarajan P, Shlipak M, Coca S, Parikh CR; TRIBE-AKI Consortium.

Ann Thorac Surg. 2017 Dec;104(6):2072-2079. doi: 10.1016/j.athoracsur.2017.04.038. Epub 2017 Aug 16.

6.

Relationship of Kidney Injury Biomarkers with Long-Term Cardiovascular Outcomes after Cardiac Surgery.

Parikh CR, Puthumana J, Shlipak MG, Koyner JL, Thiessen-Philbrook H, McArthur E, Kerr K, Kavsak P, Whitlock RP, Garg AX, Coca SG.

J Am Soc Nephrol. 2017 Dec;28(12):3699-3707. doi: 10.1681/ASN.2017010055. Epub 2017 Aug 14.

7.

Evaluating biomarkers for prognostic enrichment of clinical trials.

Kerr KF, Roth J, Zhu K, Thiessen-Philbrook H, Meisner A, Wilson FP, Coca S, Parikh CR.

Clin Trials. 2017 Dec;14(6):629-638. doi: 10.1177/1740774517723588. Epub 2017 Aug 10.

8.

Urinalysis findings and urinary kidney injury biomarker concentrations.

Nadkarni GN, Coca SG, Meisner A, Patel S, Kerr KF, Patel UD, Koyner JL, Garg AX, Philbrook HT, Edelstein CL, Shlipak M, El-Khoury J, Parikh CR; TRIBE-AKI Consortium Investigators.

BMC Nephrol. 2017 Jul 6;18(1):218. doi: 10.1186/s12882-017-0629-z.

9.

Methodological issues in current practice may lead to bias in the development of biomarker combinations for predicting acute kidney injury.

Meisner A, Kerr KF, Thiessen-Philbrook H, Coca SG, Parikh CR.

Kidney Int. 2016 Feb;89(2):429-38. Review.

10.

RiGoR: reporting guidelines to address common sources of bias in risk model development.

Kerr KF, Meisner A, Thiessen-Philbrook H, Coca SG, Parikh CR.

Biomark Res. 2015 Jan 24;3(1):2. doi: 10.1186/s40364-014-0027-7. eCollection 2015.

11.

Developing risk prediction models for kidney injury and assessing incremental value for novel biomarkers.

Kerr KF, Meisner A, Thiessen-Philbrook H, Coca SG, Parikh CR.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1488-96. doi: 10.2215/CJN.10351013. Epub 2014 May 22. Review.

Supplemental Content

Loading ...
Support Center